Protagonist Therapeutics (PTGX) Return on Invested Capital (2018 - 2026)

Protagonist Therapeutics has disclosed Return on Invested Capital across 7 years of filings, most recently posting 0.0% for Q1 2026.

• Return on Invested Capital for Q1 2026 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, up 17.0% from the prior year.
• Return on Invested Capital came in at 0.0% for Q1 2026 at Protagonist Therapeutics, up from 0.0% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.0% in Q1 2024 to a low of 0.14% in Q4 2024.
• The 3-year median for Return on Invested Capital is 0.0% (2025), against an average of 0.02%.
• Peak annual rise in Return on Invested Capital reached 14 bps in 2025, while the deepest fall reached 1 bps in 2025.
• Protagonist Therapeutics' Return on Invested Capital stood at 0.14% in 2024, then jumped by 98 bps to 0.0% in 2025, then increased by 12 bps to 0.0% in 2026.
• The last three Return on Invested Capital figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.